Understanding how PTMs regulate MHC turnover is essential for developing targeted cancer immunotherapies, as manipulating these pathways could enhance immune cell maturation, improve T cell responses, and increase the effectiveness of immune checkpoint inhibitors and other immunotherapies. The gene discussed is HLA-C; the disease is cancer.